Protaryx™ Medical Welcomes David Mester as New CEO, Spearheading Innovative Advancements in Transseptal Access Technology
[Baltimore Maryland, September 11, 2023] – Protaryx Medical, a pioneering leader in medical device innovation, proudly announces the appointment of David Mester, MBA as its new Chief Executive Officer (CEO). With a remarkable career spanning over 30 years in the structural heart medical device industry, David Mester brings a wealth of experience and expertise to guide Protaryx into a new era of growth and innovation. Protaryx Medical is renowned for its groundbreaking Protaryx Transseptal Access Device, a cutting-edge technology that…
Read MoreProtaryx Medical Announces $8.3M in Funding
Protaryx Medical Announces $8.3M in Funding for First-in-Class Technology for Left Atrial Access in Transcatheter Cardiac Procedures
Read More